S. Wang et Ps. Low, FOLATE-MEDIATED TARGETING OF ANTINEOPLASTIC DRAGS, IMAGING AGENTS, AND NUCLEIC-ACIDS TO CANCER-CELLS, Journal of controlled release, 53(1-3), 1998, pp. 39-48
The receptor for the vitamin, folic acid, is overexpressed on a number
of human tumors, including cancers of the ovary, kidney, uterus, test
is, brain, colon, lung, and myelocytic blood cells. Conjugates of foli
c acid linked via its gamma-carboxyl to either a single drug molecule
or assembly of molecules can bind to and enter receptor-expressing can
cer cells via folate receptor-mediated endocytosis. Because the affini
ty of folate conjugates for cell surface folate receptors is high (K-D
<similar (K-D similar to 10(-10) M), folic acid derivatization allows
the selective delivery of diagnostic and therapeutic agents to cancer
cells in the presence of normal cells. This review will summarize stud
ies aimed at folate-mediated targeting of protein toxins, imaging agen
ts, antisense oligodeoxynucleotides, genes, and liposomes specifically
to cancer cells in vitro and in vivo. (C) 1998 Elsevier Science B.V.